Literature DB >> 8546417

Adenovirus and adeno-associated virus as vectors for gene therapy.

K I Berns1, C Giraud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8546417     DOI： 10.1111/j.1749-6632.1995.tb44735.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  12 in total

1.  Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.

Authors:  X Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Role for highly regulated rep gene expression in adeno-associated virus vector production.

Authors:  J Li; R J Samulski; X Xiao
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 3.  Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.

Authors:  Ana Rey-Rico; Magali Cucchiarini
Journal:  Bioengineered       Date:  2016-04       Impact factor: 3.269

4.  Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Authors:  P Wu; W Xiao; T Conlon; J Hughes; M Agbandje-McKenna; T Ferkol; T Flotte; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 5.  Current Trends in Viral Gene Therapy for Human Orthopaedic Regenerative Medicine.

Authors:  Jagadeesh Kumar Venkatesan; Ana Rey-Rico; Magali Cucchiarini
Journal:  Tissue Eng Regen Med       Date:  2019-02-21       Impact factor: 4.169

6.  Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus.

Authors:  Z Sandalon; D V Gnatenko; W F Bahou; P Hearing
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex.

Authors:  Jason O'Donnell; Kenneth A Taylor; Michael S Chapman
Journal:  Virology       Date:  2009-01-13       Impact factor: 3.616

8.  Complement yourself: Transcomplementation rescues partially folded mutant proteins.

Authors:  Liudmila Cebotaru; William B Guggino
Journal:  Biophys Rev       Date:  2014-03-01

9.  Comparison of osteogenic potentials of human rat BMP4 and BMP6 gene therapy using [E1-] and [E1-,E2b-] adenoviral vectors.

Authors:  Hongwei Li; Jin Zhong Li; Debra D Pittman; Andy Amalfitano; Gerald R Hankins; Gregory A Helm
Journal:  Int J Med Sci       Date:  2006-06-01       Impact factor: 3.738

10.  Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications.

Authors:  Massimo S Fiandaca; Krystof S Bankiewicz; Howard J Federoff
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.